Showing 7881-7890 of 8879 results for "".
- UK Study: Psoriasis Diagnoses in Primary Care Delayed by Up to 5 Yearshttps://practicaldermatology.com/news/uk-study-psoriasis-diagnoses-in-primary-care-delayed-by-up-to-5-years/2461322/Psoriasis may be underdiagnosed in UK primary care settings, according to research out of the University of Manchester in The British Journal of General Practice. Patients who are later diagnosed with psoriasis are twice as likely to be prescribed steroid or antifungal creams t
- Ivermectin to Treat Scabies on Mass Scale in Solomon Islandshttps://practicaldermatology.com/news/ivermectin-to-treat-scabies-on-mass-scale-in-solomon-islands/2461317/The anti-parasitic drug ivermectin will be rolled out on mass scale in the Solomon Islands to prevent scabies.
- Study: This Is When to Use Adjuvant Therapy in Patients with Early Stage 3A Melanomahttps://practicaldermatology.com/news/study-this-is-when-to-use-adjuvant-therapy-in-patients-with-early-stage-3a-melanoma/2461313/
- Online Extra: Let’s Talk About Truncal Acnehttps://practicaldermatology.com/news/online-extra-lets-talk-about-truncal-acne/2461304/While often trivialized as a cosmetic skin disease, acne is in fact an inflammatory skin condition with a complex pathogenesis associated with a significant physical and psychological burden. Approximately 50% of people with facial acne also have truncal acne manifesting on the back, shoulders, a
- La Roche-Posay, American Cancer Society Partner to Improve Patient and Caregiver Quality of Lifehttps://practicaldermatology.com/news/la-roche-posay-american-cancer-partner-to-improve-patient-and-caregiver-quality-of-life/2461299/La Roche-Posay US is joining forces with the American Cancer Society (ACS) to further the support of cancer patients, survivors, caregivers, and the oncology community as well as raise awareness of cancer treatments' skin side effects. Since 1905, La Roche-Posay has been committed to improvin
- Pulse Biosciences Scores FDA 510(k) Clearance of Expanded Energy Settings for CellFX Systemhttps://practicaldermatology.com/news/pulse-biosciences-scores-fda-510k-clearance-of-expanded-energy-settings-for-cellfx-system/2461289/The U.S. Food and Drug Administration (FDA) gave 510(k) clearance tp expanded energy settings for use with Pulse Biosciences, Inc.’s CellFX System treatments tips in dermatology. “Pulse Biosciences is dedicated to providing dermatologists a superior solution for the treatmen
- Lubriderm x AdoptAClassroom.org Sweepstakes Helps Support Teachers, Classroomshttps://practicaldermatology.com/news/lubriderm-x-adoptaclassroomorg-sweepstakes-helps-support-teachers-classrooms/2461276/
- Sciton Taps Bryant Wong as First Chief Financial Officerhttps://practicaldermatology.com/news/sciton-taps-bryant-wong-as-first-chief-financial-officer/2461246/Bryant Wong is Sciton’s first Chief Financial Officer, effective immediately. The announcement was made at Sciton's 25th Anniversary celebration. The year 2022 exemplifies Sciton's ongoing commitment to quality and improvement, with recognition such as 2022 Company of the
- The Aeshetic Show: Organizers Highlight Top Reasons to Attendhttps://practicaldermatology.com/news/the-aeshetic-show-organizers-highlight-top-reasons-to-attend/2461244/Unique in its multidisciplinary approach, The Aesthetic Show has, for more that 15 years, covered the rapidly-expanding field of aesthetic medicine. Attendees can unite with contemporaries across various medical disciplines, learn trailblazing techniques, and discover the groundbreaking solutions
- Castle Biosciences and OHSU Team Up to Fight Melanomahttps://practicaldermatology.com/news/castle-biosciences-and-ohsu-team-up-to-fight-melanoma/2461243/